Artos AI is a Y Combinator company offering an AI-powered platform for document creation and management in the life sciences. Its tools are designed to help biopharma organizations bring products to market faster and more cost-effectively by supporting work across the document lifecycle, from source data to final drafts. The platform provides an end-to-end suite for regulatory submissions, including INDs, NDAs, and BLAs, and supports documents such as clinical study reports, investigator’s brochures, summaries, and overviews.

Artos combines AI-assisted drafting with custom templates, section regeneration, audit logs, search, and workflow automations. Teams can use downstream visualizations and source traceability to follow data and content across documents. The platform is designed for collaboration across medical writing, chemistry, manufacturing and controls (CMC), regulatory affairs, regulatory intelligence, IT, and engineering teams, with workflows tailored to different organizational needs.

Artos also offers free eCTD templates and public literature research tools, alongside information about its security practices, legal policies, responsible AI use, and integrations.